Pathophysiology and management of bone disease in multiple myeloma

Carfilzomib-lenalidomide-dexamethasone vs lenalidomide-dexamethasone in relapsed multiple myeloma by previous treatment.

Blood cancer journal·2017

Carfilzomib-dexamethasone vs bortezomib-dexamethasone in relapsed or refractory multiple myeloma by cytogenetic risk in the phase 3 study ENDEAVOR.

Leukemia·2016

Impact of prior treatment on patients with relapsed multiple myeloma treated with carfilzomib and dexamethasone vs bortezomib and dexamethasone in the phase 3 ENDEAVOR study.

Leukemia·2016

New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG).

Leukemia·2013

Carfilzomib in multiple myeloma patients with renal impairment: pharmacokinetics and safety.

Leukemia·2013

Management of treatment-emergent peripheral neuropathy in multiple myeloma.

Leukemia·2011

Mechanisms of Resistance to Immune Checkpoint Inhibitors and Therapeutic Strategies to Overcome Them: An Integrative Review.

Cancer investigation·2026

Predictive Value of the High-Sensitivity C-Reactive Protein/HDL-Cholesterol Ratio for Cardiovascular and Cancer-Specific Mortality in Cancer Survivors: A Study from NHANES 2015-2018.

Cancer investigation·2026

Precision Pancreatic Cancer Care: From Early Detection to Adaptive Precision Oncology.

Cancer investigation·2026

Measurement Properties of the Brazilian-Portuguese Version of Memorial Symptom Assessment Scale in Hospitalized Patients Undergoing Chemotherapy: A Longitudinal Study.

Cancer investigation·2026

Cancer Stem Cell-Targeted Therapies in Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis.

Cancer investigation·2026

Incidence, Management, and Clinical Outcomes of Cardiovascular Adverse Events in Patients Receiving ALK Inhibitors for Advanced Non-Small Cell Lung Cancer: A Real-World Single-Center Analysis.

Cancer investigation·2026

Clinical Impact of the C-Reactive Protein-Albumin-Lymphocyte Index as a Prognostic Biomarker in Patients With Recurrent Pancreatic Cancer.

In vivo (Athens, Greece)·2026

Wearable perspiration sensor for continuous inflammation tracking in inflammatory bowel disease.

Inflammatory bowel diseases·2026

Proof-of-Concept Study of Hyperpolarized [1-13C]Pyruvate MRI in Participants with Hepatocellular Carcinoma.

Radiology. Imaging cancer·2026

Primary Biliary Cholangitis in the Middle East: A Review of Current Challenges and Treatment Approaches.

Cureus·2026

Distinct metabolomic profiles in lean and non-lean polyendocrine metabolic ovarian syndrome.

Journal of assisted reproduction and genetics·2026

First-Pass Perfusion and T1-weighted Dixon Imaging as Emerging Biomarkers of Pericardial Disease.

Radiology. Cardiothoracic imaging·2026

Related Experiment Videos

Pathophysiology and management of bone disease in multiple myeloma

Related Concept Videos

Carfilzomib-lenalidomide-dexamethasone vs lenalidomide-dexamethasone in relapsed multiple myeloma by previous treatment.

Carfilzomib-dexamethasone vs bortezomib-dexamethasone in relapsed or refractory multiple myeloma by cytogenetic risk in the phase 3 study ENDEAVOR.

Impact of prior treatment on patients with relapsed multiple myeloma treated with carfilzomib and dexamethasone vs bortezomib and dexamethasone in the phase 3 ENDEAVOR study.

New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG).

Carfilzomib in multiple myeloma patients with renal impairment: pharmacokinetics and safety.

Management of treatment-emergent peripheral neuropathy in multiple myeloma.

Mechanisms of Resistance to Immune Checkpoint Inhibitors and Therapeutic Strategies to Overcome Them: An Integrative Review.

Predictive Value of the High-Sensitivity C-Reactive Protein/HDL-Cholesterol Ratio for Cardiovascular and Cancer-Specific Mortality in Cancer Survivors: A Study from NHANES 2015-2018.

Precision Pancreatic Cancer Care: From Early Detection to Adaptive Precision Oncology.

Measurement Properties of the Brazilian-Portuguese Version of Memorial Symptom Assessment Scale in Hospitalized Patients Undergoing Chemotherapy: A Longitudinal Study.

Cancer Stem Cell-Targeted Therapies in Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis.

Incidence, Management, and Clinical Outcomes of Cardiovascular Adverse Events in Patients Receiving ALK Inhibitors for Advanced Non-Small Cell Lung Cancer: A Real-World Single-Center Analysis.

Clinical Impact of the C-Reactive Protein-Albumin-Lymphocyte Index as a Prognostic Biomarker in Patients With Recurrent Pancreatic Cancer.

Wearable perspiration sensor for continuous inflammation tracking in inflammatory bowel disease.

Proof-of-Concept Study of Hyperpolarized [1-13C]Pyruvate MRI in Participants with Hepatocellular Carcinoma.

Primary Biliary Cholangitis in the Middle East: A Review of Current Challenges and Treatment Approaches.

Distinct metabolomic profiles in lean and non-lean polyendocrine metabolic ovarian syndrome.

First-Pass Perfusion and T1-weighted Dixon Imaging as Emerging Biomarkers of Pericardial Disease.

Related Experiment Videos

Pathophysiology and management of bone disease in multiple myeloma

Related Concept Videos

Related Articles